Business Context and Reporting Period
Company: Harvard Bioscience, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: February 27, 2014
Reporting Period: The filing announces financial results for the three months and the full year ended December 31, 2013.
Key Financial Metrics
This Form 8-K serves as a notification of a press release and does not contain specific financial data within the text of the filing itself. The document states that details regarding revenue, profit, cash flow, margins, debt, and liquidity are contained in the press release furnished as Exhibit 99.1. Consequently, the filing text does not provide clear values for these metrics.
Material Changes
The filing does not list specific material changes or comparative financial data. It references a press release for the announcement of results for the periods ended December 31, 2013, but does not summarize the variances versus prior periods in this document.
Guidance, Outlook, and Risks
Management Commentary: The company announced a conference call to be held at 11:00 AM EST on February 27, 2014, to discuss the results.
Legal Disclaimer: The information in Item 2.02 and Exhibit 99.1 is not deemed "filed" under Section 18 of the Securities Exchange Act of 1934 and is not subject to the liabilities of that section, nor is it incorporated by reference in other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific revenue, net income, and cash flow figures for Q4 and FY 2013.
- Verify the details of the conference call held on February 27, 2014, for management's outlook and commentary.
- Confirm whether the press release contains updated guidance for fiscal year 2014.
- Check subsequent filings (e.g., 10-K) for the audited financial statements corresponding to the year ended December 31, 2013.